Arthrex is committed to enhancing scientific knowledge by providing funding for research activities that are aligned with our strategic initiatives to help surgeons treat their patients better. Research funding by Arthrex can take the form of monetary and/or product support.
All research requests will be reviewed by the Arthrex Global Grants Committee (GGC), which is a cross-functional committee with the authority to approve, suggest modifications, or decline the research requests. Decisions will be based on objective criteria such as, but not limited to, clinical relevance, scientific impact, methodological approach, proposed budget, study timeline, and overall compliance.
The Arthrex GGC will make every effort to review research request applications within 12 weeks of submission. For all approved research requests, contractual agreement documentation must be completed. Therefore, research requests should be submitted at least 3 months prior to the project start date. Incomplete applications may delay the process. An email notification regarding the decision will be sent after the GGC meeting. The status of each research request application can also be tracked within the research portal.
No direct payments will be issued to individuals. Awarded research requests are provided without any commitment to purchase, use, or recommend Arthrex products either in the past or the future.
We receive many worthwhile requests. Unfortunately, we are unable to fund them all. It is important to note that past funding does not guarantee future approval and that submissions can be approved at an amount less than the requested one. Reviews and modifications of funding are done with consideration of fair market value.
Please note: Arthrex will only consider applications that are submitted online.